Revenue FY2025
$2.38B
Net Income
$0.77B
EPS (Basic)
$1.79
Net Margin
32.4%
ROE
7.9%
Total Equity
$9.72B
Shares Out
388M
Royalty Pharma plc — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2018–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 9 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Dorsey Asset Management
Pat Dorsey
$137.7M
9.5%
+7.9%
Patient Capital Management
Samantha McLemore
$201.8M
8.1%
(1.2%)
Torray Funds
Torray
$33.8M
4.6%
(6.7%)
Adage Capital Management
Adage Capital Management
$140.2M
0.2%
(66.6%)
Renaissance Technologies
Renaissance Technologies
$108.5M
0.1%
+144.7%
Capital World Investors
Capital World Investors
$533.6M
0.1%
+18.4%
Alps Advisors
Alps Advisors
$17.7M
0.0%
(36.5%)
Bridgewater Associates
Bridgewater Associates
$12.3M
0.0%
NEW
Holocene Advisors
Holocene Advisors
$0.3M
0.0%
(47.3%)
Insider Transactions
Reading stored insider transactions…